Introduction
Chronic myelogenous leukemia (CML), a clonal myeloproliferative disorder of the hematopoietic stem cell, is cytogenetically marked by the Philadelphia (Ph) chromosome, which originates from a reciprocal translocation involving chromosomes 9 and 22. 1 The molecular consequence of this translocation consists in the juxtaposition of the c-ABL proto-oncogene, normally located on chromosome 9, with the major breakpoint cluster region (M-BCR) on chromosome 22 . The BCR-ABL fusion gene is transcribed into a hybrid mRNA and then translated into a fusion protein (p210 BCR-ABL ) of 210 kDa, 2 which has enhanced transforming activities. 3 CML naturally progresses from a relatively benign chronic phase to an aggressive and terminal acute phase. 4 So far, the only curative treatment for CML patients remains allogeneic bone marrow transplantation which is restricted to less than 30% of the patients due to age and HLA matching limitations. 5 The existence of residual normal hematopoietic stem cells in the majority of CML patients has supported a number of strategies aimed at reducing and/or eliminating malignant stem/progenitor cells from CML marrow or blood to be used for autografting purposes. 6 Strategies to eliminate leukemic cells have focused on either in vivo purging using cytotoxic agents or biologic response modifiers followed by single or double autograft, [7] [8] [9] or in vitro purging with maintenance of marrow in long-term culture, 10 interferon-gamma, 11 mafosfamide, 12 inhibitors of protein tyrosine kinase, 13 antisense oligonucleotides targeted against BCR-ABL, 14 and stromaadherence. 15 Recently, selection of CD34 + DR − cells has also been proposed to enrich Ph-negative progenitors from CML marrow. 16 The availability of techniques allowing a (semi)-quantitative estimate of leukemic burden within a given cell sample is an essential requisite for evaluating the efficacy of in vitro purging and selection strategies. Ph chromosome positive progenitors grown in vitro in semisolid culture systems can be detected by single-colony karyotyping (SCK), whereas reversetranscription polymerase chain reaction (RT-PCR) analysis is used to detect BCR-ABL transcripts. 17 However, both these techniques have intrinsic limitations. First, in order to obtain evaluable metaphases, colonies have to be collected when cells are still dividing. Second, in approximately 10% of CML cases no Ph chromosome can be identified by cytogenetics 18 and less than 5% of Ph-negative CML patients are even BCR-ABL negative. 19 Third, RT-PCR analysis is a rather sophisticated technique requiring rigorous controls to exclude false positive and negative results. Finally, RT-PCR sensitivity represents a crucial issue dependent on several methodological variables.
Some investigators have recently raised concerns on the use of RT-PCR to detect BCR-ABL positive progenitors. 20, 21 In fact, this gene could not be uniformly expressed in CML progenitors and this might result in an overestimation of non-leukemic (BCR-ABL negative) progenitor cells which are indeed leukemic (Ph-positive) when analyzed by conventional cytogenetics. 20, 21 However, recent reports have suggested that in some instances BCR-ABL negativity may be due to either 'sampling effects', ie a very low number of template transcripts 22 or technical artifacts.
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Since RT-PCR is widely used to quantitate the percentage of leukemic colonies following in vitro manipulations of CML cells, 13, 14, 16 and the existence of Ph-positive clones with a silent BCR-ABL gene might have important implications, we analyzed by both SCK and RT-PCR individual CML-derived hematopoietic colonies. This comparative analysis was aimed at investigating whether a technical phenomenon could be responsible for the reported discrepancy in the frequency of leukemic progenitors when SCK or RT-PCR assays were used to analyze single colonies.
Materials and methods

Patients
Seven patients (four males and three females) with a Ph-positive CML were included in this study. The clinical characteristics of the patients are shown in Table 1 . On direct cytogenetic analysis, all patients had 100% Ph-positive marrow or blood metaphases with no additional chromosomal abnormality. At the time of the study, all patients were in chronic phase. Five cases were studied at diagnosis and before the initiation of any therapy, whereas the remaining two cases had been treated with hydroxyurea and interferon-alpha.
Cell separation procedures
Bone marrow and peripheral blood mononuclear cells (MNCs) from consenting patients were separated by centrifugation (400 g, 30 min, 4°C) on a Ficoll-Hypaque gradient (density, 1.077 g/ml) and suspended in RPMI-1640 (Gibco, Grand Island, NY, USA) supplemented with 20% fetal bovine serum (FBS; Stem Cell Technologies, Vancouver, Canada). CD34 + cells were enriched according to a magnetic cell sorting methodology (MACS; Miltenyi Biotec, Bergisch-Gladbach, Germany). Briefly, MNCs were labeled with a haptenized CD34 antibody (QBEND/10) which was then magnetically 
Progenitor cell assay
The assay for multilineage colony-forming units (CFU-Mix), erythroid bursts (BFU-E), and granulocyte-macrophage colony-forming units (CFU-GM) was performed as described elsewhere. 13 Briefly, MNC or CD34 + cells were plated in 35-mm Petri dishes in 1 ml aliquots of Iscove's modified Dulbecco's medium (Seromed, Berlin, Bergisch-Gladbach, Germany) containing 30% FBS (Stem Cell Technologies), 10 −4 m 2-mercaptoethanol (Gibco), and 1.1 % (w/v) methylcellulose. In order to minimize the possibility of colony overlapping, cells were plated at a low density (MNCs at 1-2 × 10 4 and CD34 + cells at 5-10 × 10 2 per dish). Cultures were stimulated with interleukin-3 (IL-3, 10 ng/ml; Sandoz, Basel, Switzerland), granulocyte colony-stimulating factor (G-CSF, 10 ng/ml; Amgen, Thousand Oaks, CA, USA), granulocyte-macrophage colonystimulating factor (GM-CSF, 10 ng/ml; Sandoz) and erythropoietin (Epo, 3 U/ml; Amgen). Progenitor cell growth was evaluated after incubation (37°C, 5% CO 2 ) for 14-18 days according to previously published criteria. 13 Four dishes were set up for each individual data point per experiment.
Long-term culture-initiating cell (LTC-IC) assay
The long-term culture-initiating cell (LTC-IC) assay was performed as previously described 13 according to Sutherland et al. 24 Briefly, test cell (3-5 × 10 6 MNC or 10 5 CD34 + ) suspensions were seeded into cultures containing a feeder layer of irradiated (8000 cGy 
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Cytogenetic analysis
Cytogenetic analysis and standard GTG-or QFQ-banding techniques were performed according to standard methods. 26 Single colony karyotyping was performed according to a previously described technique. 15, 27 Briefly, colcemid (1 g/ml, 100 l/dish) was added to 10-to 14-day-old cultures 3-4 h prior to the end of the incubation period. Single colonies were removed individually under an inverted microscope. Each colony aspirated in a methylcellulose volume of approximately 3-5 l was then transferred into a 96-well tissue culture plate containing 40 l of 0.075 m KCl and dispersed by gently pipetting up and down. Half of the cells were then harvested and processed for molecular analysis (see below), whereas the remaining cells were incubated for 25 min at 37°C and subsequently transferred onto a microscope slide pretreated with poly-l-lysine (0.1% w/v; Sigma Chemical, St Louis, MO, USA). The slides were incubated in a humid environment. Methanol/glacial acetic acid (3:1) fixative (25 l) was gently dropped onto the area of the slides where the colony had been placed. After 1 min, 0.5 ml of fixative was added, slides were air dried and metaphases suitable for analysis were sequentially Q and G banded.
Detection of BCR-ABL mRNA in individual progenitors
Half of each individual colony was processed for detection of BCR-ABL by RT-PCR as previously described. 13 Briefly, after adding 4 g of MS2 phage RNA (Boehringer Mannheim, Mannheim, Germany) as a carrier, RNA was extracted using TRIzol (Gibco), precipitated with isopropanol, washed with ethanol, dried and redissolved in RNAse-free water. 28 Total RNA from each colony was reverse-transcribed into cDNA in a 20 l reaction primed with random hexamers. 13 Total cDNA from each colony was divided into two aliquots, for detection of the BCR-ABL rearrangement and the ABL sequence, respectively. PCR amplifications were performed in 45 l reactions containing 10 l of cDNA, 0.25 mmol/l dNTP, 0.57 mmol/l of each primer (for BCR-ABL: sense 5Ј-GAA GAA GTG TTT CAG AAG CTT CTC CC-3Ј and antisense 5Ј-GAC CCG GAG CTT TTC ACC TTT AGT T-3Ј; for ABL: sense 5Ј-TTC AGC GGC CAG TAG CAT CTG ACT T-3Ј and antisense 5Ј-GAC CCG GAG CTT TTC ACC TTT AGT T-3Ј) and 2 U of Taq polymerase (Gibco) in PCR buffer (20 mmol/l Tris-HCl and 1.5 mmol/l MgCl 2 ). 29 Forty-five cycles, each consisting of denaturation at 94°C for 30 s, annealing at 60°C for 30 s and extension at 72°C for 30 s were performed using a PerkinElmer Cetus (Branchburg, NJ, USA) DNA thermal cycler. Since the majority of the colonies had an ABL signal of good quality after the first amplification, this first PCR product was not reamplified. One l of the first PCR product for BCR-ABL was reamplified with internal nested primers (sense 5Ј-GTG AAA CTC CAG ACT GCT CAC AGC A-3Ј and antisense 5Ј-TCC ACT GGC CAC AAA ATC ATC ATA CAG T-3Ј) under slightly modified conditions (35 cycles, each consisting of denaturation at 94°C for 30 s, annealing at 55°C for 30 s and extension at 72°C for 30 s). Twenty l of each PCR product were electrophoresed through a 2% agarose gel stained with ethidium bromide and photographed under UV light. The size of the BCR-ABL fragments obtained from nested PCR were 272 bp and 197 bp, depending on the position of the junction point within M-BCR. The expected product generated by PCR for ABL was 185 bp. In order to adequately control that: (1) RNA was correctly reverse-transcribed; and (2) the PCR product was generated by amplifying cDNA and not genomic DNA eventually contaminating the RNA sample, ABL sequence amplification was performed with two primers located on exon 2 and exon 3 of cDNA sequence, respectively. Only colonies positive for ABL amplification were considered evaluable. To eliminate the possibility of false positive results, 30 a blank control for RNA extraction (a tube containing RNAse-free-water which underwent all steps and failed to show any ABL or BCR-ABL signals) and a negative BCR-ABL control, consisting of RNA isolated from normal marrowderived CFU-GM were used. In addition, each PCR amplification included a control reaction without template cDNA (H 2 O blank). As positive control, RNA extracted from single K562 colonies was used.
CML test samples
In order to quantitate the minimum number of cells required to achieve an efficient RNA extraction, individual colonies composed of a mean number of 5 × 10 3 cells (range 2-10 × 10 3 ) were serially diluted in phosphate-buffered saline. For each dilution, RNA extraction, reverse-transcription and PCR amplification were performed as described above.
Statistical analysis
Four plates were scored for each data point per experiment and the results were expressed as the mean ± 1 standard error of the mean (± s.d.).
Results
Bone marrow and/or peripheral blood cells from seven Phpositive, chronic phase CML patients were cultured either in methylcellulose for 2 weeks or in long-term cultures for 5 weeks to allow the growth of committed progenitors and LTC-IC, respectively. Methylcellulose colonies generated by either MNC or CD34 + cells were individually harvested, divided into two aliquots and analyzed both at the cytogenetic level by standard techniques, and the molecular level by RT-PCR for BCR-ABL mRNA detection. A total number of 204 colonies, including MNC-derived (35%), CD34 + -derived (60%) and LTC-IC-derived (5%) progenitors, was analyzed. A mean (± s.d.) of 25 ± 16 colonies (range, 10 to 55) were harvested per patient. Usually harvested colonies contained at least 300 cells, but in some instances colonies of smaller size were harvested.
Cytogenetic analysis
Colonies were always successfully transferred onto poly-llysine-coated slides. However, evaluable metaphases could only be detected in 74 ± 16% of the colonies (Table 2) . Therefore, the mean number of colonies analyzed per patient by SCK was 18 ± 11. At least two Q-banded metaphases were analyzed for each colony and most of them were of good technical quality. All evaluable colonies were Ph-positive.
Molecular analysis
As shown in Table 2 , 161 out of 204 harvested colonies (86 ± 16%) could be evaluated by RT-PCR. The remaining colonies (43 out of 204) were not considered evaluable due to the absence of an ABL signal. In order to test if the absence of ABL amplification could be due to a decreased efficiency of RNA recovery from colonies composed of a small number of cells, we performed serial dilution experiments. As shown in Figure 1 (upper panel), ABL amplification was consistently observed when the analyzed sample contained Ͼ150 cells, whereas analysis of samples composed of 100-150 cells generated an inconsistent or poor quality ABL signal, and samples containing Ͻ100 cells were always ABL-negative. Table 3 shows that MNC-derived and CD34
+ -derived colonies revealed a similar incidence of BCR-ABL positivity.
Cytogenetic and molecular analysis
As shown in Table 2 , the mean percentage of colonies which were simultaneously evaluable by SCK and RT-PCR was 67 ± 19. The percentage of colonies which were Ph-positive and BCR-ABL positive was 97 ± 5% (Table 2 ). Only 4% of the colonies (three from MNCs and two from CD34 + cells) were BCR-ABL negative but Ph-positive, whereas no progenitor could be detected which was BCR-ABL positive and Ph-negative. As shown in Figure 1 (lower panel), serial dilution experiments demonstrated that BCR-ABL could only be amplified from colonies composed of Ͼ150 cells, whereas samples composed of 100-150 cells inconsistently produced a BCR-ABL signal, and samples containing Ͻ100 cells were always negative for BCR-ABL. By correlating the size of individually harvested colonies with the outcome of molecular analysis, it became evident that the five colonies which were BCR-ABL- negative but Ph-positive were composed of a number of leukemic cells below the detection limit of our RT-PCR assay, thus representing false negative results. The incidence of leukemic colonies was not affected by differences in cell lineage (CFU-GM vs BFU-E, data not shown), cell source (marrow vs blood) and type of junction (b3a2 vs b2a2) ( Table 2 ). 
438
Discussion
The quantitative antileukemic effects of in vitro purging and selection strategies on hematopoietic progenitors are increasingly evaluated by means of SCK and RT-PCR. The present study was undertaken in an attempt to evaluate the reliability of RT-PCR analysis, as compared to conventional cytogenetics, in detecting BCR-ABL positive colonies from different cell sources (marrow vs blood) or at different maturation stages (primitive vs committed progenitors). A significant percentage (67 ± 19%) of individual colonies obtained from MNC or CD34 + marrow or blood cells could be simultaneously evaluated by SCK and RT-PCR. All these colonies were Phpositive by cytogenetics and all but a negligible number (4%), transcribed the BCR-ABL gene.
Recent studies suggested that some Ph-positive hematopoietic progenitors have a transcriptionally 'silent' BCR-ABL. 20, 21 Keating et al 20 reported that a significant number of marrow colonies (23%) were Ph-positive and BCR-ABL-negative. Using blood progenitors, Diamond et al 31 observed a 18% discordance rate between SCK and RT-PCR which, however, was no longer evident when BCR-ABL amplification was repeated in quintuplicate.
Two main interpretations have been proposed to explain the discordant results obtained with SCK and RT-PCR. 20, 31 First, the existence in the marrow of a population of Ph-positive and BCR-ABL-positive progenitors which are released into the bloodstream, and a population of Ph-positive and BCR-ABL-negative progenitors which are not released into the bloodstream. 31 Although the mechanism for such a selective release remains unknown, the existence of a primitive cell population exhibiting the BCR-ABL gene rearrangement but not expressing either BCR-ABL mRNA or the p210 BCR-ABL fusion protein has been reported. 21 The second interpretation hypothesizes that the lack of BCR-ABL amplification might be the consequence of a poor quantity of cDNA template which would prevent a consistent and reproducible PCR amplification, thus suggesting that a technical rather than a biological phenomenon is the main reason for discordant results obtained with SCK and RT-PCR. 22, 23 In the present study, the concordance rate between SCK and RT-PCR, ie the percentage of Ph-positive progenitors which were also BCR-ABL-positive, was 97 ± 5%. Analysis of both different progenitor cell sources (marrow vs blood) or different progenitor cell maturation stages (MNC-vs CD34 + -derived progenitors) failed to reveal any discordance in the incidence of leukemic progenitors detectable by cytogenetics and RT-PCR (Tables 2 and 3) .
The difference between our results and those reported by others may be explained by a number of methodological issues. First, in one study 20 reverse-transcription was performed by dividing RNA into two aliquots. Since reverse-transcription takes place in two different tubes (ie one for BCR-ABL and one for ABL), RNA degradation or failure of reversetranscription occurring in the BCR-ABL tube might be a possible explanation for the high discordance rate between SCK and RT-PCR. In agreement with others, 31 we have reversetranscribed all mRNA into cDNA using random hexamers and then divided it into two parts for PCR amplification. Second, assessment of RNA integrity was performed by amplifying the ␤-actin gene. 21 This approach is not considered an appropriate control for RT-PCR. 32, 33 Many reports have already shown the inadequacy of this gene as a control for RT-PCR analysis due to (1) its high expression, and (2) the existence within the human genome of processed ␤-actin pseudogenes which can yield a PCR product of similar size to those generated by cDNA template. 32 As compared to ␤-actin, ABL amplification is a convenient control system because it has no pseudogenes and it is expressed at relatively low levels. 33 However, even if ABL is chosen as the control gene, problems can arise when performing a single or nested PCR with primers that span on the same exon, thus promoting the amplification of the ABL gene present in genomic DNA contaminating RNA samples, and resulting in an ABL signal even in cases of RNA loss, degradation or failure of reverse-transcription. 33 In order to amplify cDNA fragments giving rise to a PCR product whose size is different from that of contaminating genomic DNA, it is necessary to use a set of primers which spans across an intron sequence (eg between exon 2 and exon 3). 32 Since the cells we have analyzed represent a growth factorstimulated progeny of primitive or committed progenitors, our methodology was not adequate to address a biologically relevant issue regarding the level of expression of BCR-ABL in quiescent CML progenitors, which have been shown by others to carry, but not express, the BCR-ABL fusion gene. 21 Detection of transcriptionally silent Ph-positive progenitors in the G 0 phase of the cell cycle might eventually be achieved by interphase fluorescent in situ hybridization (FISH), but did not represent the objective of the present study which was aimed at comparing SCK and RT-PCR and validating the latter assay system as a tool for quantifying leukemic colonies.
The overall number of false negative colonies (ie Ph-positive and BCR-ABL-negative) detected by RT-PCR was negligible (4%). In order to investigate this issue further, we have analyzed the limits of our RT-PCR methodology by evaluating the minimum number of cells required to achieve an efficient RNA extraction. Results of experiments using a decreasing number of cells clearly demonstrated that, under the experimental conditions used in this study, an efficient RNA extraction requires more than 150 cells. Samples containing 100-150 CML cells inconsistently generate a BCR-ABL signal with an ABL signal of poor quality.
False negative colonies, ie Ph-positive and BCR-ABL-negative, we have detected showed an ABL signal of poor quality, thus suggesting that false negativity might indeed be the consequence of analyzing colonies composed of a low cell number. When the size of analyzed colonies was retrospectively re-evaluated, it was evident that false negative results were generated by colonies composed of р300 cells. By dividing these low-sized colonies into two aliquots for comparative SCK and RT-PCR analysis, the number of cells effectively analyzed by RT-PCR was indeed Ͻ150, ie in the range of cells generating poor quality ABL signals.
According to data obtained by using limiting cell numbers, we suggest that samples composed of at least 200 cells should be harvested to achieve a successful RT-PCR analysis of individual progenitors. In addition, these findings strongly support our strategy based on a single step PCR for ABL detection and a nested PCR for BCR-ABL detection. This strategy decreases the sensitivity in detecting ABL, which is known to be expressed at higher levels than BCR-ABL, and reduces the risk of overestimating negative results.
Previous studies have shown that the number of cytogenetically informative colonies was usually low because of the poor technical quality of metaphases. 20, 31 In the present study, a substantial percentage of colonies (Ͼ70%) could be analyzed by SCK. In our experience, time of exposure to colcemid and removal of methylcellulose were two crucial issues for a successful SCK. The optimal time of colcemid exposure was 3 to 5 h, whereas longer exposures resulted in damaged cells. To achieve a substantial elimination of methylcellulose which then allows optimal cell lysis, colonies remained in hypotonic solution for 25 min at 37°C. After adhesion of colonies to poly-l-lysine-coated slides, excess of hypotonic solution was not removed before addition of fixative solution. Overall, all colonies could be efficiently transferred onto slides and good quality metaphases could be obtained from 74% of harvested colonies.
In conclusion, our data demonstrate that individual colonies grown in semisolid culture assays from Ph-positive CML patients, can be indifferently analyzed by SCK or RT-PCR and support an extensive use of a carefully standardized RT-PCR assay to estimate the leukemic burden within samples which have been purged and selected in vitro.
